Journal of the Korean Ophthalmological Society 1995;36(6):930-937.
Published online June 1, 1995.
Serum Lipoprotein(a) in Diabetic Retinopathy Patients.
Ho Chun Lee, Ha Kyoung Kim, Hyung Chan Kim
Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea.
당뇨망막증환자에서의 혈청 Lipoprotein ( a ) 측정의 의의
이호천(Ho Chun Lee),김형찬(Hyung Chan Kim),김하경(Ha Kyoung Kim)
Abstract
Lipoprotein(a), a complex formed by apolipoprotein(a), apo B-100 and lipids, is considered an independent, genetically determined, predictor of cardiovascular disease. It may have antifibrinolytic properties in view of its similarity to plasmmogen. To evaluate whether lipoprotein(a) may be a risk factors in patients with diabetic retinopathy or not, we measured the circulating serum level of lipoprotein(a) in each group classified by the severity of diabetic retinopathy and control group. The serum lipoprotein(a) level was higher in the diabetic patients than in the control group, and diabetic retinopathy, which was expressed by the grade of retinopathy in the worse eye, was correlated significantly with the duration of disease, and the serum level of lipoprotein(a) independently(P<0.05). There was no correlation between the diabetic retinopathy and the age at the time of diagnosis, systolic or diastolic blood pressure, or the serum levels of HbA(IC), cholesterol, triglyceride, and total lipid. We concluded that the lipoprotein(a) may play a role as one of the independent risk factors in diabetic retinopathy.
Key Words: Diabetic retinopathy;Lipoprotein(a);Risk factor


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next